Management of recurrent cervical cancer: the place of ultra-radical surgery

dc.contributor.author	Rogo Khama O.
dc.contributor.author	Stendahl, U
dc.date.accessioned	2013-06-07T08:01:02Z
dc.date.available	2013-06-07T08:01:02Z
dc.date.issued	1993-06
dc.identifier.citation	East Afr Med J. 1993 Jun;70(6):380-5	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/8261961
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/29793
dc.description.abstract	Although mortality from cervical cancer has decreased substantially the incidence of recurrent disease, at 35-50%, remains unaltered. Many more young patients are seen with recurrent cervical cancer today. This paper reviews this problem--its diagnosis and available modes of treatment. The place of re-irradiation, chemotherapy and ultra-radical surgery are discussed and their limitations highlighted. Better patient selection and individualised treatment planning are emphasised. Newer, more objective prognostic indicators based on molecular understanding of cancer cells are mentioned as hopeful means through which patient selection and treatment could be improved in the future. In the developing world where persistent or recurrent disease is more common, the situation is unlikely to improve soon	en
dc.language.iso	en	en
dc.publisher	University of Nairobi.	en
dc.title	Management of recurrent cervical cancer: the place of ultra-radical surgery	en
dc.type	Article	en
local.publisher	Department of Obstetrics and Gynaecology	en